PREVENTIVE FOR OSTEOPOROSIS

PURPOSE:To provide the titled preventive containing activated vitamin D as an active component and effective in preventing the systemic osteoporosis occurring after bone fracture and/or operation of bone fracture. CONSTITUTION:The objective preventive contains an activated vitamin D, e.g. a compound...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIYATSU MAKOTO, YAMASHITA IZUMI, KAWAGISHI NAOKO, ARIYAMA HIROYUKI, HAMADA OSAMU, TOKUHIRO CHO, MUGIKURA CHO, TAKEMITSU YOSHIHARU, YOSHIMURA SHINICHIRO, ONOZAWA TOSHIHIRO, KAMO HIROKI, NOSE YOSHINORI, MATSUDA YOSHIHARU
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE:To provide the titled preventive containing activated vitamin D as an active component and effective in preventing the systemic osteoporosis occurring after bone fracture and/or operation of bone fracture. CONSTITUTION:The objective preventive contains an activated vitamin D, e.g. a compound selected from 1alpha-hydroxy-vitamin D, 1alpha-24-,1alpha,25- or 24,25-dihydroxy- vitamin D, 1alpha,24,25-trihydroxyvitamin D, 24, 25-F2-1alpha, 25-dihydroxy-vitamin D and 26,26,26,27,27,27-F6-1alpha,25-dihydroxy-vitamin D (especially activated vitamin D3 of the above type) as an active component. The active component is administered at a rate of usually about 0.01-10mug/day/person in 1-3 divided doses per day. Osteoporosis can be completely prevented by continuously administering the agent under the above condition in the operation or during the remedying period of bone fracture independent of the age and the bone density before the operation of the bone fracture.